Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $4.51 million as of July 22, 2024. Its market cap has decreased by -85.91% in one year.

Market Cap

4.51M

Enterprise Value

13.10M

1-Year Change

-85.91%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, Interpace Biosciences's market cap has decreased from $240.50M to $4.51M, a decrease of -98.13%. That is a compound annual growth rate of -16.37%.

Market Cap History

Date	Market Cap	% Change
Feb 24, 2021	15.90M	25.20%
Dec 31, 2020	12.70M	-33.51%
Dec 31, 2019	19.10M	-16.59%
Dec 31, 2018	22.90M	-16.42%
Dec 29, 2017	27.40M	242.50%
Dec 30, 2016	8.00M	2.56%
Dec 31, 2015	7.80M	-71.64%
Dec 31, 2014	27.50M	-62.28%
Dec 31, 2013	72.90M	-35.83%
Dec 31, 2012	113.60M	20.21%
Dec 30, 2011	94.50M	-37.42%
Dec 31, 2010	151.00M	120.44%
Dec 31, 2009	68.50M	20.39%
Dec 31, 2008	56.90M	-57.19%
Dec 31, 2007	132.90M	-7.00%
Dec 29, 2006	142.90M	-23.25%
Dec 30, 2005	186.20M	-43.09%
Dec 31, 2004	327.20M	-14.99%
Dec 31, 2003	384.90M	152.89%
Dec 31, 2002	152.20M	-50.92%
Dec 31, 2001	310.10M	-78.67%
Dec 29, 2000	1.45B	305.61%
Dec 31, 1999	358.40M	18.68%
Dec 31, 1998	302.00M	25.57%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	814.94B
Novo Nordisk	579.91B
UnitedHealth Group	520.32B
Johnson & Johnson	372.29B
Merck & Co.	318.55B
AbbVie	304.29B
AstraZeneca	244.04B
Novartis AG	207.64B

Market Cap Rankings